# Konstantinos Drosatos

Konstantinos Drosatos (Greek: Κωνσταντίνος Δροσάτος), born in Athens, Greece, is a Greek-American molecular biologist, who is the Ohio Eminent Scholar and Professor of Pharmacology and Systems Physiology at the University of Cincinnati College of Medicine in Cincinnati, Ohio, U.S. His parents were Georgios Drosatos and Sofia Drosatou; his family originates in Partheni, Euboea, Greece.

## Education and career

Drosatos received his B.Sc. from the department of biology at the Aristotle University of Thessaloniki, Greece in 2000. In 2000, he continued with graduate studies at the Molecular Biology-Biomedicine graduate program of the department of biology and the medical school of the University of Crete. He received his M.Sc. in 2002 and his Ph.D. in molecular biology-biomedicine in 2007. During his graduate studies (2002–2007) he was a visiting research scholar in the laboratory of Vassilis I. Zannis at Boston University Medical School. Following his graduation with a PhD in molecular biology-biomedicine in 2007, he joined the laboratory of Ira J. Goldberg at Columbia University, where he pursued post-doctoral training until 2012, when he was promoted to associate research scientist in the department of medicine at Columbia University. In 2014 he joined the faculty of the Lewis Katz School of Medicine at Temple University as an assistant professor in pharmacology and in 2020, he was promoted to associate professor with tenure in cardiovascular sciences (primary affiliation). In 2022, he was recruited at the University of Cincinnati College of Medicine, which he joined as the Ohio Eminent Scholar and Professor of Pharmacology and Systems Physiology

## Research interests

The research in his laboratory focuses on cardiovascular and systemic metabolism and particularly on signaling mechanisms that link cardiac stress in diabetes, sepsis and ischemia with altered myocardial fatty acid metabolism. His published work focuses on the transcriptional regulation of proteins that underlie lipoprotein metabolism, cardiac and systemic fatty acid metabolism, and mitochondrial function. His work has identified the role of Krüppel-like factor 5 (KLF5) in the regulation of cardiac fatty acid metabolism in diabetes and ischemic heart failure, as well as how cardiac lipotoxicity leads to cardiac dysfunction, and the importance of cardiac fatty acid oxidation and mitochondrial integrity for the treatment of cardiac dysfunction in sepsis.

## Distinctions and awards

* 2014 Outstanding Early Career Award recipient, American Heart Association, BCVS Council
* 2016 Honorary Citizen, Eastern Mani Municipality, Greece
* 2016 Visiting Professorship, UCLA Center for Systems Biomedicine
* 2017 Early Research Investigator Award, Lewis Katz School of Medicine at Temple University
* 2017 Elected Fellow (FAHA), American Heart Association
* 2019 Elected Full Member, Sigma Xi, The Scientific Research Honor Society
* 2022 Visiting Professorship, School of Medicine, Aristotle University of Thessaloniki, Greece
* 2022 Top-Reviewer 2022 for JACC: Basic to Translational Science
* 2023 Honorary Membership at the Biology Society of Cyprus
* 2023 Adjunct Professorship, European University of Cyprus
* 2023 Keynote Speaker, Trinity Translational Medicine Institute, Trinity College Dublin, Ireland
* 2023 Keynote Speaker, Vascular and Heart Research Symposium, The Fralin Biomedical Research Institute, Virginia Tech at Roanoke
* 2024 Elected Fellow of the Graduate College of the University of Cincinnati

## Leadership positions

* 2006–2010 – founding president of the board of directors, Hellenic Bioscientific Association of the USA
* 2012–2014 – president of the executive board, World Hellenic Biomedical Association
* 2019–2023 – vice-president of the executive council, ARISTEiA-Institute for the Advancement of Research & Education in Arts, Sciences & Technology
* 2020-2021 - Chair-elect of the Mid-career Committee, International Society for Heart Research-North American Section
* 2023-2026 - General Secretary of the Executive Board, KOMVOS-NODE
* 2024-2028 - President of the executive council, ARISTEiA-Institute for the Advancement of Research & Education in Arts, Sciences & Technology